Alnylam Pharmaceuticals
ALNY
#567
Rank
A$55.72 B
Marketcap
$432.31
Share price
-2.26%
Change (1 day)
67.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company